Amino Acids Lecture 4 Introduction - PowerPoint Presentation

Slide1

Amino Acids

Lecture 4

Slide2

Introduction

Amino acids play central roles both as building blocks of proteins and as intermediates in metabolism.

The 20 amino acids that are found within proteins convey a vast array of chemical versatility.

The precise amino acid content, and the sequence of those amino acids, of a specific protein, is determined by the sequence of the bases in the gene that encodes that protein. The chemical properties of the amino acids of proteins determine the biological activity of the protein.

2

Slide3

Introduction

In addition, proteins contain within their amino acid sequences the necessary information to:

determine how that protein will fold into a three dimensional structure,

and the stability of the resulting structure. It is important to keep in mind that one of the more important reasons to understand amino acid structure and properties is to be able to understand protein structure and properties.

The vastly complex characteristics of even a small, relatively simple, protein are a composite of the properties of the amino acids which comprise the protein.

3

Slide4

Amino Acid Structure

An α-amino acid consists of:

a central carbon atom, called the α carbon,

linked to an amino group, a carboxylic acid group, a hydrogen atom, and a distinctive R group.

The R group is often referred to as the side chain.

4

Slide5

Amino Acids Side Chains

Twenty kinds of side chains varying in size, shape, charge, hydrogen-bonding capacity, hydrophobic character, and chemical reactivity are commonly found.

The remarkable range of functions mediated by proteins results from the diversity and versatility of these 20 building blocks.

5

Slide6

Slide7

Two New Amino Acids?

Selenocysteine

(Sec) is recognized as the 21st amino acid but, unlike other amino acids present in proteins, it is not coded for directly in the genetic code.

Selenocysteine is encoded by a UGA codon, which is normally a stop codon; however, like the other amino acids used by cells, selenocysteine has a specialized transfer RNA (tRNA). Pyrrolysine is the 22nd naturally occurring genetically encoded amino acid.

Found in some archaea and bacteria

Slide8

Aminoacidopathies

They are rare inherited disorders of amino acid metabolism.

Hereditary disorders of amino acid processing can be the result of :

defects either in the breakdown of amino acids (activity of a specific enzyme) or in the body's ability to get the amino acids into cells (membrane transport system).

More than 100 diseases have been identified that result from inborn errors of amino acid metabolism.

Because these disorders produce symptoms early in life, newborns are routinely screened for several common ones.

Slide9

Aminoacidopathies

Phenylketonuria (PKU)

Tyrosinemia

AlkaptonuriaMaple syrup urine diseaseIsovaleric AcidemiaHomocystinuriaCystinuria

Slide10

Analysis of Amino Acids

Amino acid concentrations usually are assessed in:

(1) plasma, (2) urine, or (3) cerebrospinal fluid.

Plasma amino acid concentrations vary during the day by about 30%; therefore, it is preferable to collect specimens at the same time during the day if changes are to be monitored. Amino acid concentrations are highest in midafternoon and lowest in early morning. Plasma amino acid concentrations are high during the first days of life, especially in premature neonates, but they tend to be low in infants with low birth weight due to placental insufficiency.

Maternal values are low in the first half of pregnancy.

Slide11

Phenylketonuria (PKU)

Phenylalanine hydroxylase is an enzyme which converts phenylalanine to tyrosine.

A deficiency of this enzyme leads to a buildup of phenylalanine which results in severe mental retardation.

Phenylalanine accumulates and is metabolized by alternate degradative pathway into

phenylpyruvic

acid and others leading to mental retardation.

Slide12

Slide13

Phenylketonuria (PKU)

This condition, known as

phenylketonuria (PKU)

, is an autosomal recessive inborn error of metabolism.

Slide14

Testing for PKU

Testing is done either on the serum (Guthrie test) or on the urine.

Testing is not valid until the newborn has ingested an ample amount of the amino acid phenylalanine, which is found in human and cow’s milk.

Two or three days of intake are usually sufficient for the Guthrie test. Urine PKU testing is usually done after the infant is 4 to 6 weeks old.

Normal blood phenylalanine level is about 1.2 - 2 mg/dl. In PKU, levels may range from 6 to 80 mg/dl, usually greater than 30 mg/dl

Slide15

Guthrie bacterial inhibition assay

Spores of

B. Subtilis

are incorporated into an agar plate that contains 2-thienylalanine, a metabolic antagonist to B. Subtilis growth.

A filter paper disk impregnated with blood from the infant is placed on the agar.

If the blood level of phenylalanine exceeds a range of 3 – 4 mg/dl, the phenylalanine counteracts the antagonist, and the bacterial growth occurs.

Slide16

Guthrie bacterial inhibition assay

The infant must be at least 24h of age to ensure adequate time for enzyme and amino acid levels to develop.

The sample should be taken before the administration of antibiotics or transfusion of blood.

Premature infants can show false-positive results due to the immaturity of the liver's enzyme systems.

Slide17

Slide18

Microfluorometric assay

For the direct measurement of phenylalanine in dried blood filter discs.

It yields quantitative results, not affected by the presence of antibiotics.

The procedure is based on the fluorescence of a complex formed of phenylalanine-ninhydrin- copper in the presence of a dipeptide "l-leucyl-l-alanine“.

Slide19

Extraction using

trichloroacetic

acid

The fluorescence of the complex is measured using excitation/emission wavelengths of 360nm and 530nm respectively

Then add a mixture of

ninhydrin

,

succinate

,

leucylalanine

and copper

tartarate

Procedure

Slide20

Reference method

The reference method for quantitative serum phenylalanine is (high-performance liquid chromatography) HPLC.

The normal limits of serum phenylalanine levels of full term normal weight newborns range from 1.2 mg/dl – 2.0 mg/dl.

Slide21

Mass Spectrometry

Now, tandem mass spectrometry (MS/MS) is being used in screening for inherited disorders in newborns.

Because both the increase in phenylalanine and the decrease in tyrosine levels seen in PKU can be identified, the ratio of phenylalanine to tyrosine (

Phe/Try) can be calculated. Using the ratio between metabolites rather than an individual level increases the specificity of the measurement and lowers the false-positive rate for PKU to less than 0.01%. The MS/MS method has a greater sensitivity, detecting lower levels of phenylalanine and allowing for diagnosis of PKU as early as the first day of life.

Slide22

Slide23

Urine testing for phenylpyruvic acid

Used for diagnosis in questionable cases and for monitoring of dietary therapy.

It involves the reaction of ferric chloride with phenylpyruvic acid in urine to produce a green color.

Slide24

Prenatal diagnosis and detection of carrier status

In families with PKU, testing is now available using DNA analysis.

The test is based on revealing multiple independent mutations at the phenylalanine hydroxylase locus.

Slide25

Tyrosinemia

Tyrosinemia is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine,

Tyrosine is a building block of most proteins.

Tyrosinemia is caused by the shortage (deficiency) of one of the enzymes required for the multistep process that breaks down tyrosine. If untreated, tyrosine and its byproducts build up in tissues and organs, which leads to serious medical problems.

Slide26

Tyrosinemia

There are three types of tyrosinemia. Each has distinctive symptoms and is caused by the deficiency of a different enzyme.

Type I tyrosinemia, the most severe form of this disorder, is caused by a shortage of the enzyme fumarylacetoacetate hydrolase.

Type II tyrosinemia is caused by a deficiency of the enzyme tyrosine aminotransferase. Type III tyrosinemia is a rare disorder caused by a deficiency of the enzyme 4-hydroxyphenylpyruvate dioxygenase

Slide27

Succinylacetone

Type III tyrosinemia

nitisinone

Slide28

Tyrosinemia

Diagnostic criteria include an elevated tyrosine level using MS/MS coupled with a confirmatory test for an elevated level of the abnormal metabolite

succinylacetone

.Treatment is a low-protein diet.The drug nitisinone prevent the production of succinylacetone, a toxin that damages the liver and kidneys.

28

Slide29

Alkaptonuria

It is due to the deficiency of

homogentistate

oxidase in the tyrosine catabolic pathway.Accumulation of homogentisic acid in urine causes its darkening upon exposure to a atmosphere due to oxidation.

Alkaptonuric

patients have no immediate problems, but later high levels of homogentisic acid gradually accumulate in connective tissue, causing generalized pigmentation of these tissues and an arthritis like degeneration (cartilage, sclera ‘white of eye’, & other cartilage).

Urinalysis is done to test for alkaptonuria.

When ferric chloride is added to the urine, it will turn the urine black in patients with alkaptonuria

Slide30

Slide31

A patient with alkaptonuria. A. Urine. B. Vertebrae.

Slide32

Maple Syrup Urine Disease "MSUD"

Maple syrup urine disease is an inherited disorder in which the body is unable to process certain amino acids properly.

The condition gets its name from the distinctive sweet odor of affected infants' urine.

Mutations in 4 genes cause maple syrup urine disease.

These four genes provide instructions for making proteins that work together as a complex.

The protein complex is essential for breaking down the amino acids leucine, isoleucine, and valine, which are present in many kinds of food

Slide33

Figure 20.10 Degradation of leucine, valine, and isoleucine. TPP = thiamine pyrophosphate.

Slide34

As a result, these amino acids and their byproducts build up in the body.

Because high levels of these substances are toxic to the brain and other organs, their accumulation leads to the serious medical problems.

Slide35

Tests

A modified Guthrie test is used for neonatal screening.

The metabolic inhibitor of

B. Subtilis is 4-azaleucine. Positive test for MUSD, elevated level of leucine from a filter paper disc impregnated with infants blood will overcome the inhibitor and bacterial growth occurs.

Confirmed diagnosis is based on finding increased levels of the three amino acids in plasma and urine with leucine being in highest concentration.

A leucine level above 4 mg/dl is indicative of MUSD.

MUSD can be diagnosed prenatally by measuring the decarboxylase enzyme concentration in cells cultured from amniotic fluid.

MS/MS is also being used in testing for MSUD

Slide36

Isovaleric Acidemia

It results from a deficiency of the enzyme

isovaleryl

-CoA dehydrogenase in the degradative pathway of leucine. Health problems related to accumulation of isovaleric acid, when sever it can damage brain & nervous system.The urine of newborns can be screened for isovaleric acidemia using MS/MS or chromatography.Treatment include protein-restrictive diet and oral administration of glycine & carnitine (interact with isovaleric acid to form non-toxic readily excreted products.

Slide37

Homocystinuria

Homocysteine is an intermediate amino acid in the synthesis of cysteine from

menthionine

.Homocystinuria is caused by the impaired activity of the enzyme cystathionine -synthase which results in elevated plasma and urine levels of homocysteine and methionine.

Newborns show no abnormalities, physical defects develop gradually with age.

Clinical findings in late childhood include thrombosis, osteoporosis, dislocated eye lenses due to the lack of cysteine synthesis which is essential for collagen formation.

Slide38

Slide39

Neonatal screening with a Guthrie test using L-methionine sulfoximine as the metabolic inhibitor.

Increased plasma methionine levels from affected infants will result in bacterial growth.

Elevations in urinary homocystine can be detected by the cyanide-nitroprusside spot test (Beet-root color indicates a positive test).

HPLC is the test used as the confirmatory method, with a methionine level greater than 2 mg/dL confirming positive results from the screening test.MS/MS is also used in screening programs to test for methionine levels.

Slide40

Cystinuria

It is caused by a defect in the amino acid transport system rather than a metabolic enzyme deficiency.

Normally, amino acids are free filtered by the glomerulus and then actively reabsorbed in the proximal renal tubules.

In cystinuria, there is a 20-30 fold increase in the urinary excretion of cystine due to a genetic defect in the renal resorptive mechanism.Because cystine is relatively insoluble, it tends to precipitate in the kidney tubules and form urinary calculi.

Cystinuria can be tested by cyanide-nitroprusside test.

Ion exchange chromatography can be used for quantitative analysis of amino acids in urine or plasma.

Slide41

Slide42

Amino Acid Analysis

Blood samples drawn after 6-8 h fasting to avoid the effect of absorbed amino acids originating from dietary proteins.

The sample is collected in heparin and the plasma is promptly removed from the cells "as cells contain higher concentration of amino acids", hemolysis should be avoided for the same reason.

Deproteinization within 30 min of collection, analysis should be performed immediately or the sample should be stored at -20O

C to -40

O

C.

Slide43

Urinary amino acid analysis can be performed on a random specimen for screening purposes, but for quantitation, a 24 h urine preserved with thymol or organic solvent is required. Amniotic fluid also may be analyzed.

The method of choice is the two-dimensional chromatography, the amino acids are allowed to migrate along one solvent front, and then the chromatogram is rotated 90

O

and a second solvent migration occurs.

Slide44

Slide45

The chromatogram is visualized by staining with ninhydrin, which gives a blue color with most amino acids.

Confirmatory test for an amino acid disorder include separation and quantitation by cation-exchange chromatography using a gradient buffer elution.

HPLC reversed-phase system equipped with fluorescence detection is another choice.

Another technique that provides a highly specific and sensitive method for the measurement of amino acids is MS/MS